Skip to main content

Table 3 Relationship of triglyceride level with all-cause mortality in coronary artery disease and subgroupsa

From: The triglyceride paradox in the mortality of coronary artery disease

  All-Cause Mortality   Cardiovascular Mortality  
HR (95% CI) p HR (95% CI) p
Total patients
 Unadjusted 0.74 (0.62–0.87) <  0.001 0.77 (0.60–0.97) 0.028
 Adjustedb 0.71 (0.58–0.86) 0.001 0.67 (0.51–0.89) 0.006
ACS
 Unadjusted 0.71 (0.60–0.88) 0.001 0.80 (0.61–1.04) 0.096
 Adjustedb 0.72 (0.58–0.90) 0.003 0.69 (0.51–0.94) 0.018
AMI
 Unadjusted 0.63 (0.46–0.87) 0.005 0.53 (0.33–0.85) 0.008
 Adjustedb 0.71 (0.50–1.01) 0.057 0.51 (0.30–0.86) 0.012
Stable angina pectoris
 Unadjusted 0.74 (0.52–1.06) 0.099 0.62 (0.36–1.06) 0.086
 Adjustedb 0.61 (0.39–0.95) 0.028 0.59 (0.24–1.16) 0.127
  1. Abbreviations: HR hazard ratio, CI confidence interval, ACS acute coronary syndrome, AMI acute myocardial infarction, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, CAD coronary artery disease, BMI body mass index, GRACE score Global Registry of Acute Coronary Events score
  2. aTriglyceride levels was grouped by the tertiles; bRisk factors adjustment included age, sex, medical history (pre-hypertension, pre-diabetes mellitus, pre-myocardial infarction, pre-PCI and pre-CABG), admission examination (systolic blood pressure, heart rate, BMI and GRACE score), admission lab test (blood glucose, serum creatinine, LDL-C and HDL-C), and severity of CAD (left main artery, three vessel diseases and number of stents)